Home
About YZYBIO
Company Overview
Leadership Team
Milestones
Contact Us
Science and Technology
Research Area
Technology Platforms
Product Pipeline
Production Operation
Partnerships
Publication
Products and Research
RD Center
Scientific Progress
Investor Relations
Corporate Governance
Information Disclosure
IR Calendar
Presentation and Webcast
Press Release
Paperless Corporate Communications
News
Press Release
Media Report
Careers
Corporate Culture
Careers Development
中文
Home
About YZYBIO
About YZYBIO
Company Overview
Leadership Team
Milestones
Contact Us
Science and Technology
Science and Technology
Research Area
Technology Platforms
Product Pipeline
Production Operation
Partnerships
Publication
Products and Research
Products and Research
RD Center
Scientific Progress
Investor Relations
Investor Relations
Corporate Governance
Information Disclosure
IR Calendar
Presentation and Webcast
Press Release
Paperless Corporate Communications
News
News
Press Release
Media Report
Careers
Careers
Corporate Culture
Careers Development
简体
English
News
Witness our development together
剪窗花,写书法,这个双旦别样过
2020-12-25 17:00:00
869
12月25日
踏着圣诞宁静的钟声
友芝友生物制药
以别样的庆祝方式迎“双旦”
通过写书法和剪窗花活动,
送别2020,迎接2021新篇章。
Pren:友芝友生物CD38/CD3双抗体新药获得中国临床试验批准
Next:虚位以待 职等你来
Back
Hot
2022-12-12
科研进展 | JITC(IF: 12.5):友芝友生物双特异性抗体(抗TGF-β/PD-L1)在三阴性乳腺癌模型上取得科研新进展
View more
2022-12-07
合床试验许可:PD-L1/TGF-β双特异性抗体(Y101D)联合用药一线治疗胰腺癌临床试验获得许可
View more
2022-10-11
J Hematol Oncol.(IF: 23.168):基于友芝友生物研发的双抗体YM101的联合免疫治疗方案取得科研新进展
View more